Salt Supplementation for POTS
For patients with POTS, increase sodium intake to 6-10 grams per day (approximately 1-2 teaspoons of salt) combined with fluid intake of 2-3 liters daily, unless contraindicated by hypertension, heart failure, or renal disease. 1
Recommended Sodium and Fluid Targets
The 2017 ACC/AHA/HRS syncope guidelines provide the most directly applicable recommendations for POTS management, specifying:
The Canadian Cardiovascular Society 2020 POTS position statement does not provide specific numerical targets but emphasizes salt and fluid supplementation as foundational therapy 3.
Evidence Supporting Salt Supplementation
High-quality research demonstrates that salt supplementation in POTS produces measurable physiological benefits:
- Increases plasma volume and reduces standing heart rate 4
- Decreases orthostatic tachycardia (Δ heart rate) by expanding blood volume 4
- Lowers standing plasma norepinephrine levels 4
- Improves orthostatic tolerance time during tilt testing by 1.57 minutes 5
- Enhances peripheral vasoconstriction and cerebral autoregulation 6
In a crossover trial of 14 POTS patients, high sodium intake (300 mEq/day, approximately 7 grams) significantly reduced upright heart rate and orthostatic heart rate increment compared to low sodium intake (10 mEq/day), while increasing plasma volume 4. The benefits were most pronounced in patients with baseline urinary sodium excretion <170 mmol/day 7.
Implementation Strategy
Start with non-pharmacological measures first:
- Immediate initiation: Begin salt and fluid supplementation at diagnosis, before considering pharmacological therapy 3, 8
- Dosing: Target 6-10 grams sodium daily (can use salt tablets, electrolyte solutions, or dietary salt) 1
- Fluid pairing: Ensure adequate hydration with 2-3 liters of fluid daily 1, 2
- Timeline: Allow 4-6 weeks to assess therapeutic response 3
Monitor response by tracking:
- Orthostatic symptoms (lightheadedness, palpitations, fatigue)
- Standing heart rate
- Supine blood pressure (to detect any elevation)
Critical Contraindications and Caveats
Absolute contraindications to high salt intake:
- History of hypertension
- Heart failure or cardiac dysfunction
- Chronic kidney disease
- Current use of medications causing fluid retention 1
Important considerations:
- Salt supplementation increases supine blood pressure by only 1.03 mm Hg on average, making it relatively safe in normotensive patients 5
- The evidence base consists primarily of small, short-term studies (≤90 days), with no long-term safety data 5
- Approximately 62% of patients report symptom improvement with salt supplementation in short-term follow-up 5
- One patient in the crossover trial did not respond to high sodium intake, indicating variable individual responses 4
Integration with Other Therapies
Salt and fluid loading should be combined with:
- Compression garments (thigh-high or abdominal) to reduce venous pooling 1, 3
- Structured exercise training (starting with horizontal exercises like rowing or recumbent cycling) 3, 8
- Physical countermeasure maneuvers (leg crossing, squatting) for acute symptom management 3
If symptoms persist after 4-6 weeks of optimized non-pharmacological therapy, consider adding pharmacological agents such as midodrine, propranolol, or pyridostigmine 3.
Practical Implementation
For patients with low baseline sodium intake (urinary sodium <170 mmol/day), salt supplementation is particularly effective 7. Consider checking 24-hour urinary sodium excretion to identify these patients.
Avoid routine intravenous saline for chronic POTS management due to infection and thrombosis risks from central access 3. Reserve IV saline (1-2 L bolus over 1-2 hours) for acute rescue therapy only 3.
The long-term balance of risks and benefits remains uncertain given the absence of extended follow-up studies, but the short-term safety profile and physiological rationale support salt supplementation as first-line therapy in appropriately selected patients 1, 5.